Overview
Global drug development, clinical development and regulatory strategy. His consulting practice, Chaikin Associates LLC, focuses upon:

• International drug development/regulatory strategies for new chemical entities and biologics across multiple therapeutic areas

• Preparation of drug development plans to secure regulatory approvals in major markets, such as the United States, European Union and  Japan

• The development of exploratory drug development strategies incorporating appropriate biomarkers for proof of concept studies to enhance asset valuation

• Representation of biotechnology and pharmaceutical companies at regulatory agency meetings in the United States and Europe

• Performance of Due Diligence activities for individual drug assets or product portfolios

• Preparation of company executives for FDA advisory committee meetings.

• Advising the investment community on the scientific merit of drug
  product assets
   

Noteworthy

• Dr. Chaikin spent over 30 years in Pharma R&D and was most recently Executive Vice President for Drug Development at Kyowa Pharmaceuticals and the Head of International Drug Development for Kyowa Hakko Kogyo

• During his career in industry, Dr. Chaikin played a pivotal role in the development, registration and successful commercialization of many compounds including: Lovenox, Taxotere, Campto, Azmacort HFA, Intal HFA, Nasocort AQ, Procardia XL, Glucotrol XL, Myocet, Amaryl, Altace, Ebastine, Synercid and Serzone

• A Fellow of the American College of Clinical Pharmacology

• Author of over 70 manuscripts and abstracts

• He is the 2013 recipient of the American College of Clinical Pharmacology Nathaniel Kwitt Distinguished Service Award

• He is an Adjunct Professor in the Department of Pharmaceutics at the University of Florida College of Pharmacy

• Adjunct Professor in the Department of Pharmacy Practice and Administration at Rutgers University School of Pharmacy
   

Positions Held

• Vice President of Oncology Research and Development at Elan Pharmaceuticals

• Vice President of Worldwide Clinical Development at Rhone-Poulenc Rorer/Aventis Pharmaceuticals

• Vice President of Clinical Development at Hoechst-Roussel Pharmaceuticals

• Director of Clinical Pharmacology at Bristol Myers Squibb

• Senior Associate Medical Director and Global Project Leader for Pfizer Pharmaceuticals

• Senior Research Scientist, Drug Metabolism and Pharmacokinetics, Ortho Pharmaceutical Corporation

• Doctor of Pharmacy Degree from the University of Maryland School of Pharmacy

• Completed a Fellowship in Clinical Pharmacology at the University of Maryland Hospital in Baltimore, Maryland

​

Education

• Holds a M.D. degree from Rutgers University-New Jersey Medical School.

• He performed his internal medicine training at Robert Wood Johnson University Hospital in New Brunswick, NJ.